Stock Report

All about this stock under one free report Last Updated: 28-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Invicta Diagnostic Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: INVICTA

₹70.00

₹0.00 (0.00%)

As on 27-Aug-2026 13:32IST

Market cap

info icon

₹88 Cr

Revenue (TTM)

info icon

₹30 Cr

P/E Ratio

info icon

17.9

P/B Ratio

info icon

1.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 90.11 -- --
EBIT -- -- 30.15 -- --
Net Profit -- -- 29.54 -- --
EPS -- -- 30.01 -- --
Book Value -- -- 50.22 -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info ----22.2932.56--
Net Margin info ----16.3323.94--
Return on equity info ----40.4839.10--
Return on Capital info ----42.8538.55--
Return on Assets info ----26.5723.95--
Debt to Equity (x) info ----0.240.39--

Profitability

View Detailed Peer Comparison

ROCE

42.85

Higher than Peers by 22.60

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
42.85
38.55
--
--
--
Peer Median
20.26
19.83
33.53
37.00
--
ROE

40.48

Higher than Peers by 26.55

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
40.48
39.10
--
--
--
Peer Median
13.93
15.80
26.65
26.85
--
ROA

26.57

Higher than Peers by 16.57

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
26.57
23.95
--
--
--
Peer Median
10.00
8.30
16.54
17.58
--
EBIT Margin

22.29

Higher than Peers by 2.63

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
22.29
32.56
--
--
--
Peer Median
19.66
18.70
19.68
25.18
--
Net Margin

16.33

Higher than Peers by 4.38

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
16.33
23.94
--
--
--
Peer Median
11.96
12.26
16.78
18.16
--
Cash Profit Margin

24.66

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
24.66
36.25
--
--
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

90.11

Higher than Peers by 74.37

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
90.11
--
--
--
--
Peer Median
15.74
13.67
4.18
49.99
--
EBIT Growth

30.15

Higher than Peers by 7.55

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
30.15
--
--
--
--
Peer Median
22.60
11.16
-14.65
108.09
--
Net Profit Growth

29.54

Higher than Peers by 6.25

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
29.54
--
--
--
--
Peer Median
23.29
9.39
-16.12
151.45
--
EPS Growth

30.01

Higher than Peers by 0.58

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
30.01
--
--
--
--
Peer Median
29.43
-7.32
-35.05
150.72
--
Book Value Growth

50.26

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
50.26
--
--
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.24

Higher than Peers by 0.20

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
0.24
0.39
--
--
--
Peer Median
0.05
0.08
0.15
0.03
--
Current Ratio

2.37

Lower than Peers by 0.05

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
2.37
1.62
--
--
--
Peer Median
2.42
2.28
1.88
2.40
--
Quick Ratio

2.18

Lower than Peers by 0.19

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
2.18
1.45
--
--
--
Peer Median
2.37
2.33
1.78
3.09
--
Interest Coverage

29.51

Higher than Peers by 21.90

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
29.51
51.80
--
--
--
Peer Median
7.61
10.16
11.52
12.12
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

4.84

Lower than Peers by 5.78

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
4.84
5.40
--
--
--
Peer Median
10.62
7.60
14.45
9.16
--
Asset Turnover

1.62

Higher than Peers by 0.81

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
1.62
1.00
--
--
--
Peer Median
0.81
0.77
0.86
1.18
--
Receivable days

14.01

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
14.01
19.71
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

5.44

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
5.44
9.08
--
--
--
Peer Median
--
--
--
--
--
Payable days

-3,135.74

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
-3,135.74
-1,344.36
--
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

3,155.19

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
3,155.19
1,373.15
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
--
--
--
--
--
Peer Median
59.48
60.28
46.86
69.67
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
--
--
--
--
--
Peer Median
9.63
8.84
6.59
10.70
--
EV/EBITDA

1.05

Lower than Peers by 47.11

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
1.05
0.36
--
--
--
Peer Median
48.17
47.88
27.71
45.91
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Invicta Diagnostic
--
--
--
--
--
Peer Median
8,622
9,694
5,629
5,992
--
loading...
loading...
loading...
loading...